Skip to search formSkip to main contentSkip to account menu

BRL 32872

Known as: BRL-32872 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Benzamides

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2007
2007
Anti-arrhythmic Effects of INa, IKr, and Combined IKr–ICaL Blockade in an Experimental Model of Acute Stretch-Related Atrial Fibrillation
IntroductionAtrial dilatation is commonly associated with atrial fibrillation (AF), but the electrophysiological mechanisms and… 
Review
2006
Review
2006
The antiarrhythmic drug BRL-32872.
BRL-32872 is a new antiarrhythmic drug with balanced class-III and class-IV actions as categorized by the Vaughan-Williams… 
Review
2003
Review
2003
IKr channel blockers: novel antiarrhythmic agents.
There have been extensive efforts to develop I(Kr) channel blockers as a new antiarrhythmic agent for atrial or ventricular… 
1998
1998
Comparative effects of glibenclamide, tedisamil, dofetilide, E-4031, and BRL-32872 on protein kinase A-activated chloride current in guinea pig ventricular myocytes.
The modulation of the protein kinase A-activated chloride current (PKA-I[Cl]) may lead to modification of the cardiac action… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)